[{"Assets_0_Q3_USD":154192000.0,"CommonStockSharesOutstanding_0_Q3_shares":39461318.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-16542000.0,"NetIncomeLoss_1_Q3_USD":-5571000.0,"NetIncomeLoss_3_Q3_USD":-22097000.0,"StockholdersEquity_0_Q3_USD":135411000.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]